Free Trial

Organogenesis (ORGO) News Today

Organogenesis logo
$2.89 -0.08 (-2.79%)
As of 10:06 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ORGO Latest News

Organogenesis Holdings Inc. stock logo
Lazard Asset Management LLC Purchases 94,514 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)
Lazard Asset Management LLC raised its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 122.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 171,694 shares of the company's stock after purchasin
Organogenesis Holdings Inc. stock logo
Soleus Capital Management L.P. Acquires 645,000 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)
Soleus Capital Management L.P. increased its holdings in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,484,876 shares of the company's stock after acqui
Organogenesis Holdings Inc. stock logo
Jacobs Levy Equity Management Inc. Sells 232,865 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)
Jacobs Levy Equity Management Inc. lessened its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 82.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 48,613 shares of the company's stock after selling 2
Organogenesis Holdings Inc. stock logo
Deutsche Bank AG Sells 2,393,857 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO)
Deutsche Bank AG trimmed its position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 49.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,449,835 shares of the company's stock after selling
Organogenesis Holdings Inc. stock logo
Dimensional Fund Advisors LP Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Dimensional Fund Advisors LP boosted its holdings in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 18.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,789,265 shares of the c
Organogenesis Holdings Inc. stock logo
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Trimmed by AQR Capital Management LLC
AQR Capital Management LLC cut its stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 43.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,522,154 shares of the company's stock after selling 1,188,452 s
Organogenesis Holdings Inc. stock logo
Organogenesis (ORGO) Projected to Post Quarterly Earnings on Thursday
Organogenesis (NASDAQ:ORGO) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-organogenesis-holdings-inc-stock/)
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Shares Up 3.9% - Here's What Happened
Organogenesis (NASDAQ:ORGO) Trading 3.9% Higher - Here's Why
Organogenesis Holdings Inc. stock logo
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Raised by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 280,997 shares of the company's stock after purchasing
Organogenesis Holdings Inc. stock logo
97,950 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Jump Financial LLC
Jump Financial LLC purchased a new stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 97,950 shares of the company's stock, valued at approxima
Organogenesis Holdings Inc. stock logo
73,172 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Acquired by XTX Topco Ltd
XTX Topco Ltd bought a new stake in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 73,172 shares of the company's stock, valued at approximat
Organogenesis Holdings Inc. stock logo
Renaissance Technologies LLC Boosts Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Renaissance Technologies LLC increased its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 31.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,073,500 shares of the company's stock aft
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Trading Down 3.8% - Should You Sell?
Organogenesis (NASDAQ:ORGO) Shares Down 3.8% - What's Next?
Organogenesis Holdings Inc. stock logo
Norges Bank Purchases Shares of 482,200 Organogenesis Holdings Inc. (NASDAQ:ORGO)
Norges Bank purchased a new stake in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 482,200 shares of the company's stock, valued at approximately $1,543,00
CMS reviewing coverage policies for skin substitute products
Organogenesis Holdings Inc. stock logo
Prudential Financial Inc. Has $761,000 Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO)
Prudential Financial Inc. increased its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 92.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,720 shares of the company's stock
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Stock Price Down 5.8% - Should You Sell?
Organogenesis (NASDAQ:ORGO) Trading Down 5.8% - Here's Why
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Shares Gap Up - Should You Buy?
Organogenesis (NASDAQ:ORGO) Shares Gap Up - Here's What Happened
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Stock Price Up 9.5% - Time to Buy?
Organogenesis (NASDAQ:ORGO) Stock Price Up 9.5% - Here's What Happened
Organogenesis Holdings Inc. stock logo
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Position Raised by Bank of New York Mellon Corp
Bank of New York Mellon Corp grew its position in Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) by 35.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 418,820 shares of the company's stock after purchasin
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Trading Up 3.5% - What's Next?
Organogenesis (NASDAQ:ORGO) Trading Up 3.5% - Still a Buy?
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Trading Down 2.1% - What's Next?
Organogenesis (NASDAQ:ORGO) Stock Price Down 2.1% - What's Next?
Organogenesis Holdings Inc. stock logo
Organogenesis Holdings Inc. (NASDAQ:ORGO) Director Sells $127,500.00 in Stock
Organogenesis Holdings Inc. (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll sold 25,000 shares of the company's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $5.10, for a total transaction of $127,500.00. Following the sale, the director now directly owns 166,879 shares of the company's stock, valued at $851,082.90. This represents a 13.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Stock Price Up 9.1% After Analyst Upgrade
Organogenesis (NASDAQ:ORGO) Trading 9.1% Higher After Analyst Upgrade
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Price Target Raised to $6.00
Morgan Stanley increased their price target on Organogenesis from $4.00 to $6.00 and gave the company an "equal weight" rating in a research note on Wednesday.
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Stock Price Down 6.2% - Here's What Happened
Organogenesis (NASDAQ:ORGO) Shares Down 6.2% - Time to Sell?
Organogenesis price target raised to $6 from $4 at Morgan Stanley
BTIG Sticks to Its Buy Rating for Organogenesis Holdings (ORGO)
Organogenesis Holdings Inc. stock logo
Cornerstone Investment Partners LLC Buys Shares of 50,502 Organogenesis Holdings Inc. (NASDAQ:ORGO)
Cornerstone Investment Partners LLC purchased a new position in shares of Organogenesis Holdings Inc. (NASDAQ:ORGO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 50,502 shares of the company's stock,
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Here's Why
Organogenesis (NASDAQ:ORGO) Shares Gap Down - Time to Sell?
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Sets New 12-Month High - Should You Buy?
Organogenesis (NASDAQ:ORGO) Hits New 1-Year High - Time to Buy?
Organogenesis Holdings Inc. stock logo
Organogenesis (NASDAQ:ORGO) Issues Earnings Results
Organogenesis (NASDAQ:ORGO - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.07. Organogenesis had a negative return on equity of 2.69% and a negative net margin of 1.62%.
Organogenesis price target raised to $7 from $6 at BTIG
Lake Street Remains a Buy on Organogenesis Holdings (ORGO)
Get Organogenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter.

ORGO Media Mentions By Week

ORGO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ORGO
News Sentiment

1.78

1.03

Average
Medical
News Sentiment

ORGO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ORGO Articles
This Week

4

2

ORGO Articles
Average Week

Get Organogenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ORGO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ORGO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners